Mecasia, Rissa Mae .
HRN: 27-81-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2025
CEFUROXIME 500MG (TAB)
10/02/2025
10/08/2025
PO
500mg
2 Times A Day
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes